Porton Fine Chemicals Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.023x

Porton Fine Chemicals Ltd cash flow conversion efficiency. Based on the latest financial reports, Porton Fine Chemicals Ltd (300363) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥126.55 Million ≈ $18.52 Million USD) by net assets (CN¥5.49 Billion ≈ $803.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Porton Fine Chemicals Ltd (2009–2024)

Cash flow conversion efficiency of Porton Fine Chemicals Ltd from 2009 to 2024. This chart illustrates how Porton Fine Chemicals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 300363 stock price for real-time trading data and today's change.

Porton Fine Chemicals Ltd Cash Flow Conversion Ratio Explained

Porton Fine Chemicals Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Porton Fine Chemicals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Porton Fine Chemicals Ltd ranked by their cash flow conversion efficiency. Also see market value of Porton Fine Chemicals Ltd for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Thai President Foods Public Company Limited
BK:TFMAMA
0.024x
Nanjing Sunlord Electronics Corporation LTD
SHE:300975
-0.001x
Winpak Ltd.
TO:WPK
0.005x
Gubre Fabrikalari TAS
IS:GUBRF
0.108x
Diebold Nixdorf, Incorporated
NYSE:DBD
-0.021x
Woolworths Holdings Ltd
JSE:WHL
0.247x
SIRIUS REAL ESTATE LTD.
F:EYI
N/A
Shanghai Chinafortune Co Ltd
SHG:600621
0.369x

Annual Cash Flow Conversion Efficiency for Porton Fine Chemicals Ltd (2009–2024)

The table below shows the annual cash flow conversion efficiency of Porton Fine Chemicals Ltd from 2009 to 2024. Review cash generation quality of Porton Fine Chemicals Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥5.41 Billion
≈ $791.83 Million
CN¥405.53 Million
≈ $59.34 Million
0.075x -27.33%
2023-12-31 CN¥6.10 Billion
≈ $892.61 Million
CN¥629.06 Million
≈ $92.05 Million
0.103x -73.97%
2022-12-31 CN¥6.47 Billion
≈ $947.10 Million
CN¥2.56 Billion
≈ $375.26 Million
0.396x +245.42%
2021-12-31 CN¥4.19 Billion
≈ $612.56 Million
CN¥480.17 Million
≈ $70.26 Million
0.115x -22.83%
2020-12-31 CN¥3.39 Billion
≈ $496.54 Million
CN¥504.37 Million
≈ $73.81 Million
0.149x +29.63%
2019-12-31 CN¥3.06 Billion
≈ $448.41 Million
CN¥351.37 Million
≈ $51.42 Million
0.115x +70.75%
2018-12-31 CN¥2.88 Billion
≈ $421.91 Million
CN¥193.62 Million
≈ $28.33 Million
0.067x -66.38%
2017-12-31 CN¥1.45 Billion
≈ $212.07 Million
CN¥289.46 Million
≈ $42.36 Million
0.200x -4.09%
2016-12-31 CN¥1.37 Billion
≈ $200.49 Million
CN¥285.33 Million
≈ $41.75 Million
0.208x +118.72%
2015-12-31 CN¥1.18 Billion
≈ $172.60 Million
CN¥112.31 Million
≈ $16.43 Million
0.095x -31.71%
2014-12-31 CN¥874.42 Million
≈ $127.96 Million
CN¥121.92 Million
≈ $17.84 Million
0.139x -47.62%
2013-12-31 CN¥428.43 Million
≈ $62.69 Million
CN¥114.05 Million
≈ $16.69 Million
0.266x -23.60%
2012-12-31 CN¥327.76 Million
≈ $47.96 Million
CN¥114.21 Million
≈ $16.71 Million
0.348x +31.02%
2011-12-31 CN¥246.01 Million
≈ $36.00 Million
CN¥65.43 Million
≈ $9.57 Million
0.266x +21.40%
2010-12-31 CN¥163.21 Million
≈ $23.88 Million
CN¥35.75 Million
≈ $5.23 Million
0.219x -44.12%
2009-12-31 CN¥81.60 Million
≈ $11.94 Million
CN¥31.99 Million
≈ $4.68 Million
0.392x --

About Porton Fine Chemicals Ltd

SHE:300363 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.87 Billion
CN¥12.77 Billion CNY
Market Cap Rank
#6132 Global
#1114 in China
Share Price
CN¥23.50
Change (1 day)
+7.06%
52-Week Range
CN¥13.32 - CN¥29.41
All Time High
CN¥97.10
About

Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial. It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, produc… Read more